BGMA Managing Director To Be A Panel Member At The 16th Annual Generics And Patent Strategies Conference, 13-14 May 2013, London
SMi Group is very pleased to announce that the BGMA (British Generics Manufacturers Association) will be taking part in a panel discussion at the 16th annual Generics and Patent Strategies conference this May in London.
“I am very happy to participate in this generics event which is covering a wide range of important industry themes and issues.” – Warwick Smith, Managing Director, BGMA
The British Generic Manufacturers Association (BGMA) represents the interests of UK-based manufacturers and suppliers of generic medicines and promotes the development and understanding of the generic medicines industry in the United Kingdom.
Warwick Smith will be a leading member in the panel discussion on “Should Generics be looking to Biosimilars?” alongside Merck, Interpharm Consultancy, Medicines Assessment and IMS Health.
This unique panel discussion will take place in the session looking at “Essential Tools for Commercialisation” which will also include a presentation by the European Commission covering Recent Developments in Antitrust Enforcement in the Pharma Sector.
Presentation highlights will include:
- Overview of Commissions current enforcement activity
- Update on Patent Settlement Monitoring
- Interaction between regulatory and competition issues
Paul Csiszar, Director, Basic Industries, Manufacturing and Agriculture, European Commission
For more information go online at http://www.smi-online.co.uk/goto/pharma-generics40.asp Alternatively contact Jonathan Collins on tel: +44 (0) 20 7827 6734 or email: [email protected]
Generics and Patent Strategies, 13-14 May 2013, London
SMi Group Ltd